COMMUNIQUÉS West-GlobeNewswire

Raw Garden Launches a Higher Standard in Distillate All-In-One
07/10/2026
"Disti Made Different" New 1-gram AIO brings Raw Garden's clean cannabis standard to an everyday price, in 12 strain-inspired flavors SANTA BARBARA, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Raw Garden , one of [...]
Alignment Health Expands to Three New California Counties and Adds Hoag and Astrana Health for 2027
07/10/2026
Growth into Kern, Kings and Tulare counties and an expanded provider network give California Medicare beneficiaries more local care options ORANGE, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an [...]
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
07/10/2026
In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 2 1 SD is most prevalent type of chronic inducible urticaria (CIndU) 2 [...]
BrewDog’s Winning Streak Rolls on with Gold at the Scottish Beer Awards
07/10/2026
Hazy Jane Tropical and Krush Test Dummy take Gold as BrewDog builds on its recent sweep at the 2026 World Beer Awards. ELLON, Scotland, Oct. 07, 2026 (GLOBE NEWSWIRE) -- BrewDog , a leader in U.K. craft beer and one of [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
07/10/2026
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 7 octobre 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
Ipsen - Septembre 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
07/10/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Ipsen - September 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
07/10/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Resolution Adopted at the Extraordinary General Meeting of Genmab A/S Including Grant of Restricted Stock Units to Board Members
07/10/2026
Company Announcement COPENHAGEN, Denmark; October 7, 2026 – Genmab A/S (Nasdaq: GMAB) Today, Genmab A/S held an Extraordinary General Meeting. At the Extraordinary General Meeting the proposal from the Board of [...]
Greenline Expands to Retail with Pajaro Dispensary Grand Opening and Ribbon Cutting on Friday, October 9
07/10/2026
Vertically Integrated Monterey Bay Cultivator Brings Award-Winning Indoor Strains—Including ‘Orange Tree’—Directly to Watsonville Shelves at Grower-Direct Prices WATSONVILLE, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- [...]
ALK upgrades its full-year outlook on strong tablet sales
07/10/2026
Inside Information ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that the 2026 full-year financial outlook has been upgraded reflecting a strong growth momentum in tablet sales across regions. Revenue is now [...]
Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
07/10/2026
Full one-year results from the KYSA-8 registrational trial in stiff person syndrome to be reported, demonstrating sustained clinical benefit and a well-tolerated safety profile with no high-grade CRS or ICANS and no [...]
Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home
07/10/2026
Caregivers say they need clearer pain management plans, earlier education, and practical support on non-opioid options before a loved one undergoes surgery BRISBANE, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Pacira [...]
Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum
07/10/2026
WALTHAM, Mass., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that [...]
Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease
07/10/2026
Solengepras 150 mg achieved a statistically significant reduction in daily OFF time, with benefit seen at Week 2 Statistically significant improvements in secondary endpoints of ON time without troublesome dyskinesia [...]
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
07/10/2026
REDWOOD CITY, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper” or the “Company”), a clinical stage biotechnology company focused on the design and development of innovative [...]
Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
07/10/2026
ATSN-201 demonstrated structural and functional benefit in Parts A and B, including microperimetry improvements exceeding the level the FDA has defined as supportive of potential approval Atsena also reported new data [...]
AltruBio to Present Data from ALTB-268 Phase 2a Trial on Ulcerative Colitis at United European Gastroenterology (UEG) Week 2026
07/10/2026
SAN FRANCISCO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical-stage biotech company developing novel immune modulators to address the unmet need in immunological and [...]
Bexorg Awarded Up to $28.3 Million from ARPA-H to Advance Human Brain Translational Pharmacology for CNS Drug Development
07/10/2026
- Three-phase, 36-month award aims to extend BrainEx perfusion from 24 hours to up to two weeks, enabling longitudinal studies of human brain biology and therapeutic responses - NEW HAVEN, Conn., Oct. 07, 2026 (GLOBE [...]
VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
07/10/2026
As the FDA opens the door to non-animal safety testing, VivoSim's human-relevant models are already helping lower drug costs SAN DIEGO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” [...]

Pages